Induction of Noxa-Mediated Apoptosis by Modified Vaccinia Virus Ankara Depends on Viral Recognition by Cytosolic Helicases, Leading to IRF-3/IFN-β-Dependent Induction of Pro-Apoptotic Noxa

English version České info

Viral infection is a stimulus for apoptosis, and in order to sustain viral replication many viruses are known to carry genes encoding apoptosis inhibitors. F1L, encoded by the orthopoxvirus modified vaccinia virus Ankara (MVA) has a Bcl-2-like structure. An MVA mutant lacking F1L (MVAΔF1L) induces apoptosis, indicating that MVA infection activates and F1L functions to inhibit the apoptotic pathway. In this study we investigated the events leading to apoptosis upon infection by MVAΔF1L. Apoptosis largely proceeded through the pro-apoptotic Bcl-2 family protein Bak with some contribution from Bax. Of the family of pro-apoptotic BH3-only proteins, only the loss of Noxa provided substantial protection, while the loss of Bim had a minor effect. In mice, MVA preferentially infected macrophages and DCs in vivo. In both cell types wt MVA induced apoptosis albeit more weakly than MVAΔF1L. The loss of Noxa had a significant protective effect in macrophages, DC and primary lymphocytes, and the combined loss of Bim and Noxa provided strong protection. Noxa protein was induced during infection, and the induction of Noxa protein and apoptosis induction required transcription factor IRF3 and type I interferon signalling. We further observed that helicases RIG-I and MDA5 and their signalling adapter MAVS contribute to Noxa induction and apoptosis in response to MVA infection. RNA isolated from MVA-infected cells induced Noxa expression and apoptosis when transfected in the absence of viral infection. We thus here describe a pathway leading from the detection of viral RNA during MVA infection by the cytosolic helicase-pathway, to the up-regulation of Noxa and apoptosis via IRF3 and type I IFN signalling.

Vyšlo v časopise: Induction of Noxa-Mediated Apoptosis by Modified Vaccinia Virus Ankara Depends on Viral Recognition by Cytosolic Helicases, Leading to IRF-3/IFN-β-Dependent Induction of Pro-Apoptotic Noxa. PLoS Pathog 7(6): e32767. doi:10.1371/journal.ppat.1002083
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1002083

Souhrn

Zdroje

1. ClemRJFechheimerMMillerLK 1991 Prevention of apoptosis by a baculovirus gene during infection of insect cells. Science 254 1388 1390

2. GalluzziLBrennerCMorselliETouatZKroemerG 2008 Viral control of mitochondrial apoptosis. PLoS Pathog 4 e1000018

3. PostigoAFerrerPE 2009 Viral inhibitors reveal overlapping themes in regulation of cell death and innate immunity. Microbes Infect 11 1071 1078

4. YouleRJStrasserA 2008 The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9 47 59

5. KvansakulMvan DelftMFLeeEFGulbisJMFairlieWD 2007 A structural viral mimic of prosurvival Bcl-2: a pivotal role for sequestering proapoptotic Bax and Bak. Mol Cell 25 933 942

6. GrahamSCBaharMWCooraySChenRAWhalenDM 2008 Vaccinia virus proteins A52 and B14 Share a Bcl-2-like fold but have evolved to inhibit NF-kappaB rather than apoptosis. PLoS Pathog 4 e1000128

7. GonzalezJMEstebanM 2010 A poxvirus Bcl-2-like gene family involved in regulation of host immune response: sequence similarity and evolutionary history. Virol J 7 59

8. WasilenkoSTStewartTLMeyersAFBarryM 2003 Vaccinia virus encodes a previously uncharacterized mitochondrial-associated inhibitor of apoptosis. Proc Natl Acad Sci U S A 100 14345 14350

9. FischerSFLudwigHHolzapfelJKvansakulMChenL 2006 Modified vaccinia virus Ankara protein F1L is a novel BH3-domain-binding protein and acts together with the early viral protein E3L to block virus-associated apoptosis. Cell Death Differ 13 109 118

10. KvansakulMYangHFairlieWDCzabotarPEFischerSF 2008 Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands. Cell Death Differ 15 1564 1571

11. ChenLWillisSNWeiASmithBJFletcherJI 2005 Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 17 393 403

12. ZhaiDYuEJinCWelshKShiauCW 2010 Vaccinia virus protein F1L is a caspase-9 inhibitor. J Biol Chem 285 5569 5580

13. HengartnerMO 2000 The biochemistry of apoptosis. Nature 407 770 776

14. ChipukJEMoldoveanuTLlambiFParsonsMJGreenDR 2010 The BCL-2 family reunion. Mol Cell 37 299 310

15. PostigoACrossJRDownwardJWayM 2006 Interaction of F1L with the BH3 domain of Bak is responsible for inhibiting vaccinia-induced apoptosis. Cell Death Differ 13 1651 1662

16. WasilenkoSTBanadygaLBondDBarryM 2005 The vaccinia virus F1L protein interacts with the proapoptotic protein Bak and inhibits Bak activation. J Virol 79 14031 14043

17. CampbellSHazesBKvansakulMColmanPBarryM 2010 Vaccinia virus F1L interacts with Bak using highly divergent Bcl-2 homology domains and replaces the function of Mcl-1. J Biol Chem 285 4695 4708

18. TaylorJMQuiltyDBanadygaLBarryM 2006 The vaccinia virus protein F1L interacts with Bim and inhibits activation of the pro-apoptotic protein Bax. J Biol Chem 281 39728 39739

19. PostigoAMartinMCDoddingMPWayM 2009 Vaccinia-induced epidermal growth factor receptor-MEK signalling and the anti-apoptotic protein F1L synergize to suppress cell death during infection. Cell Microbiol 11 1208 1218

20. WillisSNChenLDewsonGWeiANaikE 2005 Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev 19 1294 1305

21. LetaiABassikMCWalenskyLDSorcinelliMDWeilerS 2002 Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2 183 192

22. UrenRTDewsonGChenLCoyneSCHuangDC 2007 Mitochondrial permeabilization relies on BH3 ligands engaging multiple prosurvival Bcl-2 relatives, not Bak. J Cell Biol 177 277 287

23. DewsonGKratinaTSimHWPuthalakathHAdamsJM 2008 To trigger apoptosis, Bak exposes its BH3 domain and homodimerizes via BH3:groove interactions. Mol Cell 30 369 380

24. KastenmullerWDrexlerILudwigHErfleVPeschelC 2006 Infection of human dendritic cells with recombinant vaccinia virus MVA reveals general persistence of viral early transcription but distinct maturation-dependent cytopathogenicity. Virology 350 276 288

25. ChahroudiAGarberDAReevesPLiuLKalmanD 2006 Differences and similarities in viral life cycle progression and host cell physiology after infection of human dendritic cells with modified vaccinia virus Ankara and vaccinia virus. J Virol 80 8469 8481

26. LallemandCBlanchardBPalmieriMLebonPMayE 2007 Single-stranded RNA viruses inactivate the transcriptional activity of p53 but induce NOXA-dependent apoptosis via post-translational modifications of IRF-1, IRF-3 and CREB. Oncogene 26 328 338

27. TakeuchiOAkiraS 2008 MDA5/RIG-I and virus recognition. Curr Opin Immunol 20 17 22

28. DelaloyeJRogerTSteiner-TardivelQGLe RoyDKnaup ReymondM 2009 Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome. PLoS Pathog 5 e1000480

29. WaiblerZAnzagheMFrenzTSchwantesAPohlmannC 2009 Vaccinia virus-mediated inhibition of type I interferon responses is a multifactorial process involving the soluble type I interferon receptor B18 and intracellular components. J Virol 83 1563 1571

30. StaibCKislingSErfleVSutterG 2005 Inactivation of the viral interleukin 1beta receptor improves CD8+ T-cell memory responses elicited upon immunization with modified vaccinia virus Ankara. J Gen Virol 86 1997 2006

31. HornungVLatzE 2010 Intracellular DNA recognition. Nat Rev Immunol 10 123 130

32. LudwigHSuezerYWaiblerZKalinkeUSchnierleBS 2006 Double-stranded RNA-binding protein E3 controls translation of viral intermediate RNA, marking an essential step in the life cycle of modified vaccinia virus Ankara. J Gen Virol 87 1145 1155

33. YoneyamaMKikuchiMNatsukawaTShinobuNImaizumiT 2004 The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5 730 737

34. RothenfusserSGoutagnyNDiPernaGGongMMonksBG 2005 The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I. J Immunol 175 5260 5268

35. TsungKYimJHMartiWBullerRMNortonJA 1996 Gene expression and cytopathic effect of vaccinia virus inactivated by psoralen and long-wave UV light. J Virol 70 165 171

36. PagliariLJKuwanaTBonzonCNewmeyerDDTuS 2005 The multidomain proapoptotic molecules Bax and Bak are directly activated by heat. Proc Natl Acad Sci U S A 102 17975 17980

37. BouilletPMetcalfDHuangDCTarlintonDMKayTW 1999 Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286 1735 1738

38. CampbellSHazesBKvansakulMColmanPBarryM 2010 Vaccinia virus F1L interacts with Bak using highly divergent Bcl-2 homology domains and replaces the function of Mcl-1. J Biol Chem 285 4695 4708

39. OdaEOhkiRMurasawaHNemotoJShibueT 2000 Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288 1053 1058

40. BeschRPoeckHHohenauerTSenftDHackerG 2009 Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells. J Clin Invest 119 2399 2411

41. WeberAKirejczykZBeschRPotthoffSLeverkusM 2010 Proapoptotic signalling through Toll-like receptor-3 involves TRIF-dependent activation of caspase-8 and is under the control of inhibitor of apoptosis proteins in melanoma cells. Cell Death Differ 17 942 951

42. AblasserABauernfeindFHartmannGLatzEFitzgeraldKA 2009 RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat Immunol 10 1065 1072

43. ChiuYHMacmillanJBChenZJ 2009 RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 138 576 591

44. KatoHTakeuchiOSatoSYoneyamaMYamamotoM 2006 Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441 101 105

45. WeberAKirejczykZPotthoffSPlonerCHackerG 2009 Endogenous Noxa Determines the Strong Proapoptotic Synergism of the BH3-Mimetic ABT-737 with Chemotherapeutic Agents in Human Melanoma Cells. Transl Oncol 2 73 83

46. StaibCDrexlerISutterG 2004 Construction and isolation of recombinant MVA. Methods Mol Biol 269 77 100

47. GasteigerGKastenmullerWLjapociRSutterGDrexlerI 2007 Cross-priming of cytotoxic T cells dictates antigen requisites for modified vaccinia virus Ankara vector vaccines. J Virol 81 11925 11936

48. da FonsecaFGWolffeEJWeisbergAMossB 2000 Characterization of the vaccinia virus H3L envelope protein: topology and posttranslational membrane insertion via the C-terminal hydrophobic tail. J Virol 74 7508 7517

49. WeberAPaschenSAHegerKWilflingFFrankenbergT 2007 BimS-induced apoptosis requires mitochondrial localization but not interaction with anti-apoptotic Bcl-2 proteins. J Cell Biol 177 625 636

50. UnoTHirabayashiKMuraiMYanoJOzatoK 2005 The role of IFN regulatory factor-3 in the cytotoxic activity of NS-9, a polyinosinic-polycytidylic acid/cationic liposome complex, against tumor cells. Mol Cancer Ther 4 799 805